Seeing Is Believing
Currently out of the existing stock ratings of Justin Kim, 46 are a BUY (85.19%), 8 are a HOLD (14.81%).
Analyst Justin Kim works at OPPENHEIMER with a stock forecast success ratio of 61.87% fulfilled within 286.18 days on average.
Justin Kim’s has documented 102 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CYTK, Cytokinetics at 04-Mar-2024.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for AUPH (AURINIA PHARMACEUTICALS) at 10/28/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.04 (6.81%) receiving and performance score of 68.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
28
1 years 9 months 1 days ago
1/4 (25%)
$15.6 (125.81%)
169
Hold
5
$-5 (-50.00%)
15
1 years 9 months 20 days ago
3/3 (100%)
$-6.4 (-56.14%)
193
Hold
8
1 years 9 months 20 days ago
2/2 (100%)
$-18.1 (-69.35%)
282
Which stock is Justin Kim is most bullish on?
Which stock is Justin Kim is most reserved on?
What Year was the first public recommendation made by Justin Kim?